THE PHARMACOLOGY OF CARIPRAZINE, A NOVEL D3-PREFERRING D3/D2 ANTAGONIST-PARTIAL AGONIST ANTIPSYCHOTIC

被引：0
|
作者：
Kiss, Bela [1 ]
Seneca, Nick [2 ]
Szikra, Judit [1 ]
Nemethy, Zsolt [1 ]
Saghy, Katalin [1 ]
Laszy, Judit [1 ]
Gyertyan, Istvan [1 ]
机构：
[1] Gedeon Richter, Budapest, Hungary
[2] Karolinska Inst, Stockholm, Sweden
来源：
SCHIZOPHRENIA RESEARCH | 2010年 / 117卷 / 2-3期
关键词：
D O I：
10.1016/j.schres.2010.02.680
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：379 / 380
页数：2
相关论文
共 50 条
  • [41] Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
    Chien, Ellen Y. T.
    Liu, Wei
    Zhao, Qiang
    Katritch, Vsevolod
    Han, Gye Won
    Hanson, Michael A.
    Shi, Lei
    Newman, Amy Hauck
    Javitch, Jonathan A.
    Cherezov, Vadim
    Stevens, Raymond C.
    [J]. SCIENCE, 2010, 330 (6007) : 1091 - 1095
  • [42] Palindore: A potent, selective D2/D3 partial agonist for the treatment of schizophrenia.
    Stack, G
    Marquis, K
    Rosenzweig-Lipson, S
    Mewshaw, RE
    Bravo, B
    Tran, M
    Scerni, R
    Brennan, J
    Coupet, J
    Spangler, T
    Wasik, T
    Shropshire, A
    Piesla, M
    Grauer, S
    Uzzle, C
    Andree, T
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U176 - U176
  • [43] Cariprazine, an orally active D2/D3 receptor antagonist, for the potential treatment of schizophrenia, bipolar mania and depression
    Gruender, Gerhard
    [J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (07) : 823 - 832
  • [44] Reevaluation of PNU-99194A discriminative stimulus effects -: Potentiation by both a D2 antagonist and a D3/D2 agonist
    Baker, LE
    Prus, AJ
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 73 (04) : 753 - 758
  • [45] GAS CHROMATOGRAPHIC SEPARATION OF VITAMINS D2 AND D3 AS ISOTACHYSTEROL D2 AND D3
    SHEPPARD, AJ
    LACROIX, DE
    PROSSER, AR
    [J]. FEDERATION PROCEEDINGS, 1968, 27 (02) : 675 - &
  • [46] PHARMACODYNAMICS OF D2/D3 AGONIST-INDUCED SLEEP
    Yoshida, Y.
    Urakami, T.
    Yoneda, H.
    Nishino, S.
    [J]. SLEEP, 2009, 32 : A11 - A12
  • [47] F15063, an innovative antipsychotic with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties:: (I) in vitro, neurochemical and neuroendocrine profiles
    Newman-Tancredi, A.
    Assie, M. B.
    Martel, J. C.
    Cosi, C.
    Heusler, P.
    Slot, L. Bruins
    Carilla-Durand, E.
    Cussac, D.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S144 - S145
  • [48] Occupancy of dopamine D2 and D3 receptors by a novel D3 partial agonist BP1.4979: a [11C]-(+)-PHNOPET study in humans
    Di Ciano, Patricia
    Mansouri, Esmaeil
    Tong, Junchao
    Wilson, Alan A.
    Houle, Sylvain
    Boileau, Isabelle
    Duvauchelle, Thierry
    Robert, Philippe
    Schwartz, Jean Charles
    Le Foll, Bernard
    [J]. NEUROPSYCHOPHARMACOLOGY, 2019, 44 (07) : 1284 - 1290
  • [49] Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors:: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist
    Burstein, ES
    Ma, J
    Wong, S
    Gao, Y
    Pham, E
    Knapp, AE
    Nash, NR
    Olsson, R
    Davis, RE
    Hacksell, U
    Weiner, DM
    Brann, MR
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 1278 - 1287
  • [50] VITAMINS D2 AND D3
    不详
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1965, 1 (5446): : 1364 - +
12345